
CiteAb provides world-class data that accelerates scientific research. Collected using innovative tech that combines machine learning and human reviewing to understand reagent use from scientific publications, this data powers all of our products. Our search engine ranks products by citations, fundamentally changing the way researchers from the world's top universities, pharmaceutical and biotechnology companies find reagents that work for their experiments. We also support reagent suppliers, finance companies, scientific publishers and biopharma/biotech companies with our data services, helping these companies make more informed business decisions and accelerate their work. Our goal is to be providing the majority of researchers and suppliers with the data they need to drive progress in the life science sector.
CiteAb の市場拡大を追跡しています
CiteAb の海外展開を競合と比較
バーは比較対象企業間の相対的な規模を示します。
列5| 企業 | 市場 | 新規市場 | モメンタム | アクティビティ | 拡大スコア |
|---|---|---|---|---|---|
CiteAb自社 | 0 | 0 | — | 0 | 0 |
現在採用していません
この企業をフォローして、変化があり次第通知を受け取るにはサインアップしてください。
We're thrilled to announce the expansion of our partnership with Springer Nature! 🎉With millions of reagents on the market, it can be incredibly time consuming for researchers to find suitable products for their work.And the stakes are high: millions of patient samples, billions in research budgets and precious lab time is wasted when ineffective reagents are used in experiments. Through our expanded partnership with Springer Nature we will now analyse their complete portfolio of publications t ...
終了Try our search tools for free
終了Try our search tools for free
終了AbcamのVP、Will Howat博士がCiteAb 2026年度優秀個人影響力賞を受賞。Abcamは神経科学分野のIHC年間サプライヤー賞も受賞し、リン酸化抗体部門で高評価を獲得。CiteAb賞を12年連続受賞。
認証済みメールと直通電話を解放
無料 · カード不要
CiteAb の事業、市場、成長シグナルに関する簡潔な回答。

© 2026 Pubrio. 無断転載を禁じます。